Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 231

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation: Outcomes at 2 Years

Open access
Iung, Bernard, Armoiry, Xavier, Vahanian, Alec, Boutitie, Florent, Mewton, Nathan, Trochu, Jean-Noël, Lefèvre, Thierry, Messika-Zeitoun, David, Guerin, Patrice, Cormier, Bertrand, Brochet, Eric, Thibault, Hélène, Himbert, Dominique, Thivolet, Sophie, Leurent, Guillaume, Bonnet, Guillaume, Donal, Erwan, Piriou, Nicolas, Piot, Christophe, Habib, Gilbert, Rouleau, Frédéric, Carrié, Didier, Nejjari, Mohammed, Ohlmann, Patrick, Saint Etienne, Christophe, Leroux, Lionel, Gilard, Martine, Samson, Géraldine, Rioufol, Gilles, Maucort-Boulch, Delphine, Obadia, Jean François·2019·European Journal of Heart Failure

Abstract

Aims: The MITRA-FR trial showed that among symptomatic patients with severe secondary mitral regurgitation, percutaneous repair did not reduce the risk of death or hospitalization for heart failure at 12 months compared with guideline-directed medical treatment alone. We report the 24-month outcome from this trial. Methods and results: At 37 centres, we randomly assigned 304 symptomatic heart failure patients with severe secondary mitral regurgitation (effective regurgitant orifice area >20 mm2 or regurgitant volume >30 mL), and left ventricular ejection fraction between 15% and 40% to undergo percutaneous valve repair plus medical treatment (intervention group, n = 152) or medical treatment alone (control group, n = 152). The primary efficacy outcome was the composite of all-cause death and unplanned hospitalization for heart failure at 12 months. At 24 months, all-cause death and unplanned hospitalization for heart failure occurred in 63.8% of patients (97/152) in the intervention group and 67.1% (102/152) in the control group [hazard ratio (HR) 1.01, 95% confidence interval (CI) 0.77–1.34]. All-cause mortality occurred in 34.9% of patients (53/152) in the intervention group and 34.2% (52/152) in the control group (HR 1.02, 95% CI 0.70–1.50). Unplanned hospitalization for heart failure occurred in 55.9% of patients (85/152) in the intervention group and 61.8% (94/152) in the control group (HR 0.97, 95% CI 0.72–1.30). Conclusions: In patients with severe secondary mitral regurgitation, percutaneous repair added to medical treatment did not significantly reduce the risk of death or hospitalization for heart failure at 2 years compared with medical treatment alone.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ejhf.1616

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 231

Metadata

Authors
Iung, B., Armoiry, X., Vahanian, A., Boutitie, F., Mewton, N., Trochu, J.-N., Lefèvre, T., Messika-Zeitoun, D., Guerin, P., Cormier, B., Brochet, E., Thibault, H., Himbert, D., Thivolet, S., Leurent, G., Bonnet, G., Donal, E., Piriou, N., Piot, C., Habib, G., Rouleau, F., Carrié, D., Nejjari, M., Ohlmann, P., Saint Etienne, C., Leroux, L., Gilard, M., Samson, G., Rioufol, G., Maucort-Boulch, D., & Obadia, J. F.
Venue
European Journal of Heart Failure
Published
2019-11-18
Volume
21
Issue
12
Pages
1619-1627
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W2971720436
Cited by
231
References
2
FWCI
22.82
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.